GES

Gemoscan Canada, Inc. (TSX VENTURE:GES) (MUN:1GE)

With statistics demonstrating that nearly 30 percent of Canadians may be
affected by food sensitivities, access to affordable and comprehensive food
intolerance based nutrition and diet management systems are more important than
ever before. Starting today, Rexall(TM) and Rexall(TM) Pharma Plus(TM) stores
across Canada will be even better equipped to meet this demand with the
introduction of HEMOCODE(TM) Lite. Based on the popular HEMOCODE(TM) Food
Intolerance System, which clarifies and helps people deal with sensitivities to
250 foods and additives, HEMOCODE(TM) Lite now targets and manages for
sensitivities to 60 of the most common foods.


"This is one more way Rexall is making it easier for Canadians to feel good
about their health," said Tracey Phillips, Vice President, Pharmacy, Rexall.
"We're pleased to exclusively provide a lower-priced option for food intolerance
testing with HEMOCODE(TM) Lite and add to our many services and products that
help Canadians identify, relieve and prevent digestive issues."


HEMOCODE(TM) Lite provides easier access to those Canadians who are looking for
improved wellness through diet, but may also be looking for a more gradual and
lower-priced option. 


"Food intolerances can impede a variety of processes that occur in a healthy
body. Managing your intolerances can restore healthy function and may make your
body more efficient at absorbing the vitamins and minerals you need. Most people
also note, not only improvements in their welfare, but a feeling of greater
energy and overall wellness, after engaging with Hemocode" stated Dr. Mubina
Jiwa, ND.


Those suffering from food intolerances may experience pain and discomfort that
often adversely affects their daily functioning. Without proper management of
the offending foods, consumers may suffer unnecessarily for years or even a
lifetime. As with the original, HEMOCODE(TM) Food Intolerance System, with just
a few drops of blood, HEMOCODE(TM) Lite delivers a program, developed and
administered by licensed doctors of naturopathic medicine, that includes: a
comprehensive report of offending foods complete with personalized information
and recommendations for dietary wellness; regular naturopathic consultation;
easy-to-follow instructions and handy tools to help you in feeling your best,
but, at a lower-price.


"As food intolerances have become better understood in the scope of diet and
nutritional wellness, the need for all Canadians to have greater access to a
management tool like HEMOCODE(TM) has never been more important," says Dr.
Mubina Jiwa, Doctor of Naturopathic Medicine. 


HEMOCODE(TM) Lite is available exclusively at Rexall(TM) and Rexall(TM) Pharma
Plus(TM) stores nationwide for $129 and may be covered through extended health
care programs under naturopathy. 


ABOUT THE HEMOCODE(TM) FOOD INTOLERANCE SYSTEM 

The HEMOCODE(TM) Food Intolerance System is a personalized naturopathic
nutritional program that promotes dietary well-being. It uses patented
technology and services to provide consultation and recommendations to simplify
the management of food sensitivities. The HEMOCODE(TM) Food Intolerance System
is one of a growing number of wellness services and products offered by
pharmacies as complementary medical choices. Complementary medicine is an
adjunct to conventional medical practice, incorporating alternative modalities
and therapies with a focus on lifestyle and wellness. A statistically
significant base of practitioners and those using HEMOCODE(TM) report improved
dietary wellness and satisfaction.


ABOUT GEMOSCAN CANADA, INC. 

Gemoscan is an industry leader in food intolerance management and maintains a
first-to-market position with Canada wide distribution through select retail
partners. Founded in 2003, using its proprietary patented technology; Gemoscan
develops, owns and markets comprehensive food sensitivity and dietary management
solutions for consumers, including the HEMOCODE(TM) Food Intolerance System, a
personalized naturopathic nutritional program that promotes well-being. Gemoscan
is the first and only provider to commercialize a food intolerance management
solution directly to consumers in partnership with retailers, and today offers
the most comprehensive services available.


Gemoscan Canada, Inc. trades its shares on the Toronto Venture Exchange (TSX-V)
under the symbol GES and is quoted on the Munich, Frankfurt and Stuttgart Stock
Exchanges under the symbol 1GE.


ABOUT REXALL(TM) 

Rexall is a national drugstore chain of 420 Rexall and Rexall Pharma Plus retail
pharmacies located across Canada with a heritage dating back to 1904. Rexall is
focused on helping to make it easier for Canadians to live healthier lives
through community-focused pharmacy services, quality health care products and
working to continually enhance the customer experience. For more information
visit www.rexall.ca. 


Forward-Looking Information 

This news release contains certain "forward-looking information". All
statements, other than statements of historical fact that address activities,
events or developments that Gemoscan believes, expects or anticipates will or
may occur in the future. These forward-looking statements reflect the current
expectations or beliefs of Gemoscan based on information currently available to
Gemoscan. Forward-looking statements are subject to a number of significant
risks and uncertainties and other factors that may cause the actual results of
Gemoscan to differ materially from those discussed in the forward-looking
statements, and even if such actual results are realized or substantially
realized, there can be no assurance that they will have the expected
consequences to, or effects on Gemoscan. Any forward-looking statement speaks
only as of the date on which it is made and, except as may be required by
applicable securities laws, Gemoscan disclaims any intent or obligation to
update any forward-looking statement, whether as a result of new information,
future events or results or otherwise. Although Gemoscan believes that the
assumptions inherent in the forward-looking statements are reasonable,
forward-looking statements are not guarantees of future performance and
accordingly undue reliance should not be put on such statements due to the
inherent uncertainty therein.

Gemoscan Canada, Inc. (TSXV:GES)
Historical Stock Chart
From May 2024 to Jun 2024

Gemoscan Canada, Inc. (TSXV:GES)
Historical Stock Chart
From Jun 2023 to Jun 2024